Search Results - mohamad+navab

2 Results

Sort By:

2020-439 4F FOR AMD

Researchers at UCLA’s David Geffen School of Medicine, in collaboration with researchers from the University of Lubeck, Germany, have developed an anti-inflammatory, antiatherogenic peptide which ameliorates symptoms and progression of age-related macular degeneration (AMD) and could work to reduce the severity of other eye diseases presenting...

Published: 7/19/2023 | Inventor(s): Alan Fogelman, Mohamad Navab, Gattadahalli Anantharamaiah, Martin Rudolf

Keywords(s): Macular Degeneration, Peptide

Category(s): Platforms > Drug Delivery > Peptide Base

A Novel Method To Enhance Tg6f Amelioration Of Dyslipidemia

SummaryUCLA researchers in the Department of Medicine have developed a novel protocol that enhances the effects of Tg6F in treating dyslipidemia.BackgroundDyslipidemia is characterized as having abnormal levels of cholesterol or triglycerides in the blood, resulting in an imbalance of circulating lipids. Patients with dyslipidemia tend to have a higher...

Published: 7/19/2023 | Inventor(s): Alan Fogelman, Srinivasa Reddy, Mohamad Navab

Keywords(s): Cardiovascular, Inflammatory Diseases, Therapeutics & Vaccines

Category(s): Therapeutics, Therapeutics > Cardiovascular, Therapeutics > Inflammation And Inflammatory Diseases